Return to: Biotechnology News

Molecular Biology Enzymes Industry is Expected to Generate the Revenue Worth USD 12.69 Billion by 2021



Browse 102 market data Tables and 43 Figures spread through 184 Pages and in-depth TOC on "Molecular Biology Enzymes and Kits & Reagents Market"
http://www.marketsandmarkets.com/Market-Reports/molecular-biology-enzymes-kits-reagents-market-164131709.html
Early buyers will receive 10% customization on this report.

A number of factors such as technological advancements in the life sciences industry, increased research activities in the pharmaceutical and biotechnology sectors, rising incidences of infectious diseases and genetic disorders, and successful completion of Human Genome Project are expected to drive the growth of the molecular biology enzymes market during the forecast period.

In this report, the molecular biology enzymes and kits & reagents market is segmented on the basis of product, application, end user, and region. Based on product, molecular biology enzymes market is categorized into kits & reagents and enzymes. The kits & reagents segment is expected to account for the largest share of the market in 2016. This segment is also estimated to grow at the faster growth rate during the forecast period (2016-2021).

Get The PDF Brochure For This Report:
http://www.marketsandmarkets.com/pdfdownload.asp?id=164131709

On the basis of end user, the molecular biology enzymes market is segmented academic & research institutes, hospitals & diagnostic centers, and pharmaceutical & biotechnology companies, among other end users. The academic & research institutes segment is expected to account for the largest share of the market in 2016. However, the hospitals & diagnostic centers are projected to grow at the highest CAGR during the forecast period.

Geographically, the molecular biology enzymes and kits & reagents market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (Latin America, the Middle East, and Africa). North America is expected to account for the largest share of the molecular biology enzymes and kits & reagents market in 2016, followed by Europe, Asia-Pacific, and the Rest of the World.

Get the Sample Pages:
http://www.marketsandmarkets.com/requestsample.asp?id=164131709

The Asia-Pacific market is projected to grow at the highest CAGR and serves as a revenue pocket for companies offering molecular biology enzymes and kits & reagents.

Prominent players in the global molecular biology enzymes market include Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), New England Biolabs, Inc. (U.S.), Promega (U.S.), Illumina, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), F. Hoffmann-la Roche Ltd. (Switzerland), Takara Bio Inc. (Japan), QIAGEN N.V. (The Netherlands), and Becton, Dickinson and Company (U.S.)

About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600- ...

News Release: Molecular Biology Enzymes Industry is Expected to Generate the Revenue Worth USD 12.69 Billion by 2021
Submitted on: June 29, 2017 09:44:00 AM
Submitted by: Mayur Nath
On behalf of: www.marketsandmarkets.com/Market-Reports/molecular-biology-enzymes-kits-reagents-market-164131709.html
advertisement